Release Summary

Dorsey announced today that Martin Shkreli, biotechnology and pharmaceutical investor, and Steve Hurst, CEO of Savant HWP will discuss Shkreli’s latest deal at the 4D Symposium on September 29, 2016.

Dorsey & Whitney LLP